Table 2.
Characteristics of the Pseudomonas aeruginosa isolates derived from urine samples.
| Isolate | Antimicrobial | ||
|---|---|---|---|
| Susceptible | Resistant | Genotype | |
| 1 | TOB, AK, CN, CS | PTZ, CAZ, ATM, CIP, TTC | blaNDM, blaOXA, oprD |
| 2 | TOB, AK, CN, CS | blaOXA, oprD | |
| 3 | TOB, AK, CS | CN | blaOXA, aph(3′)-IIIa, oprD |
| 4 | TOB, AK, CN, CS | LEV | blaNDM, oprD |
| 5 | TOB, AK, CN, CS | blaCTX-M-UN, oprD | |
| 6 | TOB, AK, CN, CS | blaKPC, blaSPM, oprD | |
| 7 | TOB, AK, CN, CS | blaKPC, oprD | |
| 8 | TOB, AK, CN, CS | PTZ, CAZ | blaKPC, blaSPM, oprD |
| 9 | TOB, AK, CN, CS | blaKPC, blaNDM, blaSPM, oprD | |
| 10 | TOB, AK, CN, CS | PTZ, CAZ, ATM, TTC | blaKPC, blaSPM, blaVIM2, oprD |
| 11 | TOB, AK, CS | CN | blaKPC, blaSPM, blaOXA, oprD |
| 12 | TOB, AK, CN, CS | blaCTX-M-UN, blaKPC, oprD | |
| 13 | TOB, AK, CN, CS | blaKPC, oprD | |
| 14 | TOB, AK, CN, CS | PTZ, CAZ, CIP | blaKPC, oprD |
| 15 | TOB, AK, CN, CS | blaKPC, blaSPM, oprD | |
| 16 | TOB, AK, CN, CS | blaSPM, blaVIM, oprD | |
| 17 | TOB, AK, CS | CN | blaKPC, blaNDM, blaSPM, oprD |
| 18 | TOB, AK, CN, CS | blaSPM, blaVIM2, oprD | |
| 19 | TOB, AK, CN, CS | blaKPC, oprD | |
| 20 | TOB, AK, CN, CS | blaKPC,blaSPM, oprD | |
| 21 | TOB, AK, CN, CS | IMI | blaSPM, oprD |
| 22 | TOB, AK, CN, CS | blaSPM, oprD | |
| 23 | TOB, AK, CN, CS | blaSPM, oprD | |
| 24 | TOB, AK, CS | PTZ, CN, TTC, PRL | blaSPM, oprD |
| 25 | TOB, AK, CN, CS | blaSPM, oprD | |
Ceftazidime (CAZ), cefepime (FEP), amikacin (AK), gentamicin (CN), tobramycin (TOB), doripenem (DOR), imipenem (IMI), meropenem (MEM), aztreonam (ATM), ciprofloxacin (CIP) piperacillin (PRL), colistin (CS), levofloxacin (LEV) and ticarcillin–clavulanic acid (TTC).